Cargando…

microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway

BACKGROUND: Extrahepatic Cholangiocarcinoma (EHCC) is one of the uncommon malignancies in the digestive system which is characterized by a poor prognosis. Aberrations of miRNAs have been shown involved in the progression of this disease. In this study, we evaluated the expression and effects of miR-...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Pengfei, Li, Guodong, Bi, Wen, Yang, Lianmeng, Yao, Lei, Wu, Dequan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477414/
https://www.ncbi.nlm.nih.gov/pubmed/26077733
http://dx.doi.org/10.1186/s12885-015-1359-x
_version_ 1782377755769307136
author Qiao, Pengfei
Li, Guodong
Bi, Wen
Yang, Lianmeng
Yao, Lei
Wu, Dequan
author_facet Qiao, Pengfei
Li, Guodong
Bi, Wen
Yang, Lianmeng
Yao, Lei
Wu, Dequan
author_sort Qiao, Pengfei
collection PubMed
description BACKGROUND: Extrahepatic Cholangiocarcinoma (EHCC) is one of the uncommon malignancies in the digestive system which is characterized by a poor prognosis. Aberrations of miRNAs have been shown involved in the progression of this disease. In this study, we evaluated the expression and effects of miR-34a on EHCC. METHODS: miR-34a expression levels were detected in EHCC tissues, adjacent non-tumor tissues, normal bile duct (NBD) specimens of patients and cholangiocarcinoma (CC) cell lines by quantitative real-time polymerase chain reaction (qRT-PCR). Relationships between miR-34a with clinical characteristics of EHCC patients were further analyzed. Computational search, functional luciferase assay and western blot were further used to demonstrate the downstream target of miR-34a in CC cells. Immunohistochemistry was carried on to identify the downstream target gene of miR-34a in EHCC patients. Cell morphology, invasion and migration assays were further applied to confirm the anti-carcinogenic effects of miR-34a through the downstream target. RESULTS: miR-34a expression was significantly decreased in human EHCC tissues and CC cell lines when compared with the adjacent non-tumor tissues and normal bile duct tissues. miR-34a was found correlated with the migration and invasion in EHCC patients. Smad4 was over-expressed in most of the EHCC patients and was further demonstrated as one of the downstream targets of miR-34a, which was involved in the progression of EHCC. Moreover, activation of miR-34a suppressed invasion and migration through TGF-beta/Smad4 signaling pathway by epithelial-mesenchymal transition (EMT) in vitro. CONCLUSIONS: Taken together, our results suggest that miR-34a inhibits invasion and migration by targeting Smad4 to suppress EMT through TGF- beta/Smad signaling pathway in human EHCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1359-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4477414
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44774142015-06-24 microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway Qiao, Pengfei Li, Guodong Bi, Wen Yang, Lianmeng Yao, Lei Wu, Dequan BMC Cancer Research Article BACKGROUND: Extrahepatic Cholangiocarcinoma (EHCC) is one of the uncommon malignancies in the digestive system which is characterized by a poor prognosis. Aberrations of miRNAs have been shown involved in the progression of this disease. In this study, we evaluated the expression and effects of miR-34a on EHCC. METHODS: miR-34a expression levels were detected in EHCC tissues, adjacent non-tumor tissues, normal bile duct (NBD) specimens of patients and cholangiocarcinoma (CC) cell lines by quantitative real-time polymerase chain reaction (qRT-PCR). Relationships between miR-34a with clinical characteristics of EHCC patients were further analyzed. Computational search, functional luciferase assay and western blot were further used to demonstrate the downstream target of miR-34a in CC cells. Immunohistochemistry was carried on to identify the downstream target gene of miR-34a in EHCC patients. Cell morphology, invasion and migration assays were further applied to confirm the anti-carcinogenic effects of miR-34a through the downstream target. RESULTS: miR-34a expression was significantly decreased in human EHCC tissues and CC cell lines when compared with the adjacent non-tumor tissues and normal bile duct tissues. miR-34a was found correlated with the migration and invasion in EHCC patients. Smad4 was over-expressed in most of the EHCC patients and was further demonstrated as one of the downstream targets of miR-34a, which was involved in the progression of EHCC. Moreover, activation of miR-34a suppressed invasion and migration through TGF-beta/Smad4 signaling pathway by epithelial-mesenchymal transition (EMT) in vitro. CONCLUSIONS: Taken together, our results suggest that miR-34a inhibits invasion and migration by targeting Smad4 to suppress EMT through TGF- beta/Smad signaling pathway in human EHCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1359-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-16 /pmc/articles/PMC4477414/ /pubmed/26077733 http://dx.doi.org/10.1186/s12885-015-1359-x Text en © Qiao et al. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Qiao, Pengfei
Li, Guodong
Bi, Wen
Yang, Lianmeng
Yao, Lei
Wu, Dequan
microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
title microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
title_full microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
title_fullStr microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
title_full_unstemmed microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
title_short microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
title_sort microrna-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting smad4 through transforming growth factor-beta/smad pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477414/
https://www.ncbi.nlm.nih.gov/pubmed/26077733
http://dx.doi.org/10.1186/s12885-015-1359-x
work_keys_str_mv AT qiaopengfei microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway
AT liguodong microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway
AT biwen microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway
AT yanglianmeng microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway
AT yaolei microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway
AT wudequan microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway